Preventing cancer without killing cells

Mar 30, 2007

Inducing senescence in aged cells may be sufficient to guard against spontaneous cancer development, according to a paper published online this week in EMBO reports. It was previously unknown whether cellular senescence or programmed cell death – apoptosis – was the more important safeguard mechanism for suppressing tumours arising from dysfunctional telomeres.

Aged cells have abnormal chromosomes with dysfunctional telomeres – shorter ends – that can promote tumorigenesis in the absence of the tumour suppressor p53, and may be related to the higher incidence of cancer in older individuals.

However, in the presence of p53, dysfunctional telomeres can induce a permanent arrest of cell growth, known as senescence. Sandy Chang and colleagues studied mutant mice with dysfunctional telomeres and copies of the p53 gene that cannot initiate p53-dependent apoptosis but can execute p53-mediated senescence.

The authors found that activating the senescence pathway was sufficient to suppress spontaneous tumorigenesis. Their findings suggest that, by halting cellular proliferation, p53-mediated senescence may act as an important tumour suppressor mechanism in aged cells.

Source: European Molecular Biology Organization

Explore further: When oxygen is short, EGFR prevents maturation of cancer-fighting miRNAs

add to favorites email to friend print save as pdf

Related Stories

Recommended for you

Key find for early bladder cancer treatment

8 hours ago

Aggressive forms of bladder cancer involve the protein PODXL – a discovery that could hold the key to improved treatment, according to researchers at Lund University, Uppsala University and KTH in Sweden.

Cold plasma successful against brain cancer cells

8 hours ago

For the first time, physicists from the Max Planck Institute for Extraterrestrial Physics (MPE), biologists and physicians demonstrated the synergistic effect of cold atmospheric plasma - a partly ionized ...

User comments : 0

More news stories

J&J expects 10-plus new drug applications by 2017

(AP)—Johnson & Johnson is developing what could eventually be game-changing treatments for depression and pain, and it's aiming to apply for approval of more than 10 new medicines by 2017, executives said Thursday during ...

A hidden population of exotic neutron stars

(Phys.org) —Magnetars – the dense remains of dead stars that erupt sporadically with bursts of high-energy radiation - are some of the most extreme objects known in the Universe. A major campaign using ...